Factores de riesgo de desarrollo de dolor pélvico crónico en pacientes con endometriosis. Revisión bibliográfica.
article
OA: diamond
CC0
AI-generated summary
This literature review identifies risk factors associated with the development of chronic pelvic pain in patients diagnosed with endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
AI-generated deep summary
This narrative review compiles known and proposed risk factors in women diagnosed with endometriosis that are associated with the later development of chronic pelvic pain, discussing high-level mechanisms such as nerve infiltration/damage, inflammation, and related pain pathways. It outlines the multifactorial nature of endometriosis and its clinical symptom spectrum (including dysmenorrhea, chronic pelvic pain, dyspareunia, dyschezia, dysuria, and infertility), and it mentions both medical and surgical approaches for pain treatment in general. A key limitation is that, as a narrative review, it does not provide a structured, systematic synthesis of risk factors or specify the strength of evidence across included studies. This paper is centrally about endometriosis — it focuses on risk factors for developing chronic pelvic pain in patients with endometriosis.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
This narrative review is presented to elucidate the risk factors present in patients diagnosed with endometriosis that lead to the development of chronic pelvic pain. The ultimate goal is to establish more effective and personalized therapies, avoiding the consequences of persistent pain. Endometriosis is a chronic, benign gynecological disease characterized by the growth of endometrial-like tissue outside the uterine cavity. This ectopic tissue acts like the eutopic endometrium: it thickens, breaks down, and bleeds during the menstrual cycle. Despite being benign, endometriosis infiltrates tissues and causes an inflammatory reaction in the areas where it is implanted. Both are responsible for the clinical symptoms, including dysmenorrhea, chronic pelvic pain, dyspareunia, dyschezia, dysuria, and infertility. Endometriosis is a multifactorial disease with no known cause. Several mechanisms may contribute to pain, including direct compression or infiltration of nerves, inflammation, and nerve damage or dysfunction. Treatment of pain associated with endometriosis can be medical or surgical. A holistic understanding of the risk factors for the development of chronic pelvic pain in patients with endometriosis is essential. This understanding, along with a multidisciplinary approach, is key to proper diagnosis and treatment, with the ultimate goal of improving patients’ quality of life.
Full text
7,447 characters
· extracted from
oa-html
· click to expand
Abstract
This narrative review is presented to elucidate the risk factors present in patients diagnosed with endometriosis that lead to the development of chronic pelvic pain. The ultimate goal is to establish more effective and personalized therapies, avoiding the consequences of persistent pain. Endometriosis is a chronic, benign gynecological disease characterized by the growth of endometrial-like tissue outside the uterine cavity. This ectopic tissue acts like the eutopic endometrium: it thickens, breaks down, and bleeds during the menstrual cycle. Despite being benign, endometriosis infiltrates tissues and causes an inflammatory reaction in the areas where it is implanted. Both are responsible for the clinical symptoms, including dysmenorrhea, chronic pelvic pain, dyspareunia, dyschezia, dysuria, and infertility. Endometriosis is a multifactorial disease with no known cause. Several mechanisms may contribute to pain, including direct compression or infiltration of nerves, inflammation, and nerve damage or dysfunction. Treatment of pain associated with endometriosis can be medical or surgical. A holistic understanding of the risk factors for the development of chronic pelvic pain in patients with endometriosis is essential. This understanding, along with a multidisciplinary approach, is key to proper diagnosis and treatment, with the ultimate goal of improving patients’ quality of life.References
1. Cousins FL, McKinnon BD, Mortlock S, Fitzgerald HC, Zhang C, Montgomery GW, et al. New concepts on the etiology of endometriosis. J Obstet Gynaecol Res. 2023;49(4):1090-105.
2. Yoshino O, et al. Possible pathophysiology of endometriosis-associated pain. J Obstet Gynaecol Res. 2018;44(10):1912-20.
3. Li R, et al. Prevalence and risk factors of dysmenorrhea among female students. J Pediatr Adolesc Gynecol. 2020;33(3):258-64.
4. Karp BI, Stratton P. Endometriosis-associated chronic pelvic pain. Med. 2023;4(3):143-6.
5. Griffiths MJ, Horne AW, Gibson DA, Roberts N, Saunders PTK. Endometriosis: recent advances that could accelerate diagnosis and improve care. Trends Mol Med. 2024;30(9):875-89.
6. Liang Y, Liu D, Yang F, Pan W, Zeng F, Wu J, et al. Perineural invasion in endometriotic lesions contributes to endometriosis-associated pain. J Pain Res. 2018;11:1999-2009.
7. Sumbodo CD, Tyson K, Mooney S, Lamont J, McMahon M, Holdsworth-Carson SJ. The relationship between sleep disturbances and endometriosis: A systematic review. Eur J Obstet Gynecol Reprod Biol. 2024;293:1-8.
8. Araujo Egas CM, Revelo Benavides KM, Chicaiza López LC, Medina Altamirano DE. Factores de riesgo predisponente de endometriosis. RECIMUNDO. 2022;6(4):4-11.
9. Osuga Y, Seki Y, Tanimoto M, Kusumoto T, Kudou K, Terakawa N. Relugolix reduces endometriosis-associated pain in a dose–response manner. Fertil Steril. 2021;115:397-405.
10. Practice Committee ASRM. Treatment of pelvic pain associated with endometriosis. Fertil Steril. 2008;90(5 Suppl):S260-269.
11. Fernandez H, Agostini A, Baffet H, Chabbert-Buffet N, Descamps P, Estrade JP, et al. Update on the management of endometriosis-associated pain in France. J Gynecol Obstet Hum Reprod. 2023;52(10):102664-75.
12. Villegas-Echeverri JD, López Jaramillo JD, Herrera-Betancourt AL, López Isanoa JD. Dolor pélvico crónico: más allá de la endometriosis. Rev Peru Ginecol Obstet. 2016;62(1):77-83.
13. Pereira Calvo J, Pereira Rodríguez Y, Quirós Figueroa L. Endometriosis: diagnóstico y alternativas terapéuticas. Rev Med Sinergia. 2020;5(2):e361-e372.
14. Negrón Rodríguez J. Manejo del dolor pélvico crónico en pacientes con endometriosis. Rev Peru Ginecol Obstet. 2016;62(1):69-76.
15. Maddern J, Grundy L, Castro J, Brierley SM. Pain in Endometriosis. Front Cell Neurosci. 2020;14:590823-590838.
16. Kiser AC, Eilbeck K, Hernandez EJ, Schliep KC, Peterson CM, Yandell M. Identifying anatomical regions associated with endometriosis pain using neighbor-joining clustering. In: Proceedings of the 77th ASRM Scientific Congress & Expo. 2021:e409-e410.
17. As-Sanie S, Harris RE, Napadow V, Kim J, Neshewat G, Kairys A, et al. Changes in regional gray matter volume in women with chronic pelvic pain: a voxel-based morphometry study. American Journal of Obstetrics and Gynecology. 2012;206(6):481.e1-481.e9.
18. Song SY, Jung YW, Shin W, Park M, Lee GW, Jeong S, An S, et al. Endometriosis-Related Chronic Pelvic Pain. Biomedicines. 2023;11(10):2868-84.
19. McNamara HC, Frawley HC, Donoghue JF, Readman E, Healey M, Ellett L et al. Peripheral, Central, and Cross Sensitization in Endometriosis-Associated Pain and Comorbid Pain Syndromes. Front Reprod Health. 2021;3:729642-55.
20. Wei Y, Liang Y, Lin H, Dai Y, Yao S. Autonomic nervous system and inflammation interaction in endometriosis-associated pain. J Neuroinflammation. 2020;17:80-92.
21. Coxon L, Demetriou L, Vincent K. Current developments in endometriosis-associated pain. Cell Rep Med. 2024;5(9):101769-82.
22. Ball E, Khan KS. Recent advances in understanding and managing chronic pelvic pain. F1000Res. 2020;9:83-91.
23. Ding S, Zhu T, Tian Y, Xu P, Chen Z, Huang X, et al. Role of Brain-Derived Neurotrophic Factor in Endometriosis Pain. Reprod Sci. 2018;25(7):1045-57.
24. Aredo JV, Heyrana KJ, Karp BI, Shah JP, Stratton P. Relating Chronic Pelvic Pain and Endometriosis to Signs of Sensitization and Myofascial Pain and Dysfunction. Semin Reprod Med. 2017;35(1):88-97.
25. As-Sanie S, Shafrir AL, Halvorson L, Chawla R, Hughes R, Merz M. The Burden of Pelvic Pain Associated With Endometriosis Among Women in Selected European Countries and the United States: A Restricted Systematic Review. J Minim Invasive Gynecol. 2024;31(8):653-66.
26. Coxon L, Horne AW, Vincent K. Pathophysiology of endometriosis-associated pain: A review of pelvic and central nervous system mechanisms. Best Pract Res Clin Obstet Gynaecol. 2018;51:53-67.
27. Grinberg K, Sela Y, Nissanholtz-Gannot R. New Insights about Chronic Pelvic Pain Syndrome (CPPS). Int J Environ Res Public Health. 2020;17(4):3005-21.
28. Jones AV, Hockley JRF, Hyde C, Gorman D, Sredic-Rhodes A, Bilsland J, et al. Genome-wide association analysis of pain severity in dysmenorrhea. Pain. 2016;157:2571-81.
29. Kobayashi H, Yamada Y, Morioka S, Niiro E, Shigemitsu A, Ito F. Mechanisms of pain generation in endometriosis. Molecular Medicine Reports. 2014;9(5):1567-73.
30. Li PS, Peng XM, Niu XX, Xu L, Hung Yu Ng E, Wang CC, et al. Efficacy of acupuncture for endometriosis-associated pain. Fertil Steril. 2023;119(5):815-23.
31. Netzl J, Gusy B, Voigt B, Sehouli J, Mechsner S. Chronic Pelvic Pain in Endometriosis: Cross-Sectional Associations with Mental Disorders. J Clin Med. 2022;11:3714-28.
32. Rahmioglu N, Mortlock S, Ghiasi M, Møller PL, Stefansdottir L, Galarneau G, et al. The genetic basis of endometriosis and its polymorphisms. Nature Genetics. 2023;55(5):757-67.
33. Raimondo D, Raffone A, Renzulli F, Sanna G, Raspollini A, Bertoldo L, et al. Prevalence and Risk Factors of Central Sensitization in Women with Endometriosis. J Minim Invasive Gynecol. 2023;30(1):73-80.
34. Ruotolo A, Vannuccini S, Capezzouoli T, Pampaloni F, Cecere S, Gallucci E, et al. Diet characteristics in patients with endometriosis. J Endometr Uterine Disord. 2025;9:100094-102.
35. Yela DA, Kajikawa P, Donati L, Cursino K, Giraldo H, Benetti-Pinto CL. Deep infiltrating endometriosis treatment with dienogest: a pilot study. Arch Gynecol Obstet. 2015;292(1):120-5.
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Ask this paper
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (29)
- Autonomic nervous system and inflammation interaction in endometriosis-associated pain via openalex
- Chronic Pelvic Pain in Endometriosis: Cross-Sectional Associations with Mental Disorders, Sexual Dysfunctions and Childhood Maltreatment via openalex
- Current developments in endometriosis-associated pain via openalex
- Deep Infiltrating Endometriosis Treatment with Dienogest: A Pilot Study via openalex
- Diet characteristics in patients with endometriosis via openalex
- Dolor pélvico crónico: Más allá de la endometriosis via openalex
- Endometriosis-associated chronic pelvic pain via openalex
- Endometriosis: diagnóstico y alternativas terapéuticas via openalex
- Endometriosis: recent advances that could accelerate diagnosis and improve care via openalex
- Endometriosis-Related Chronic Pelvic Pain via openalex
- Factores de riesgo predisponente de endometriosis via openalex
- Manejo del dolor pélvico crónico en pacientes con endometriosis via openalex
- New concepts on the etiology of endometriosis via openalex
- New Insights about Chronic Pelvic Pain Syndrome (CPPS) via openalex
- Pathophysiology of endometriosis-associated pain: A review of pelvic and central nervous system mechanisms via openalex
- Perineural invasion in endometriotic lesions contributes to endometriosis-associated pain via openalex
- Peripheral, Central, and Cross Sensitization in Endometriosis-Associated Pain and Comorbid Pain Syndromes via openalex
- Prevalence and Risk Factors of Central Sensitization in Women with Endometriosis via openalex
- Recent advances in understanding and managing chronic pelvic pain in women with special consideration to endometriosis via openalex
- Relating Chronic Pelvic Pain and Endometriosis to Signs of Sensitization and Myofascial Pain and Dysfunction via openalex
- Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, reduces endometriosis-associated pain in a dose–response manner: a randomized, double-blind, placebo-controlled study via openalex
- Role of Brain-Derived Neurotrophic Factor in Endometriosis Pain via openalex
- Treatment of pelvic pain associated with endometriosis via openalex
- Update on the management of endometriosis-associated pain in France via openalex
- W3092324413 via openalex
- W4389502864 via openalex
- W2477401472 via openalex
- W4318305673 via openalex
- W4396762610 via openalex
Source provenance
- openalex
- last seen: 2026-06-30T06:04:46.332736+00:00
License: CC0
· commercial use OK